Intracellular activities of RP 59500 (quinupristin-dalfopristin) and sparfloxacin against Enterococcus faecium

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 4, 1996, Pages 886-890

  Herrera Insúa, Irene ^a   Jacques Palaz, Karen ^a   Murray, Barbara E ^a   Rakita, Robert M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; DALFOPRISTIN PLUS QUINUPRISTIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIOSTASIS; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; ENTEROCOCCUS FAECALIS; HOSPITAL INFECTION; HUMAN; HUMAN CELL; INTRACELLULAR KILLING; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0029866160     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.4.886     Document Type: Article

References (34)

1. Arduino, R. C., K. Jacques-Palaz, B. E. Murray, and R. M. Rakita. 1994. Resistance of Enterocnccus faecium to neutrophil-mediated phagocytosis. Infect Immun. 62:5587-5594.
2. Arduino, R. C., and B. E. Murray. 1993. Enterococcus antimicrobial resistance. In G. Mandell, R G. Douglass, and J. Bennett (ed.), Principles and practice of infectious diseases, update to 3rd ed Churchill-Livingstone. New York.
3. Arthur, M., and P. Courvalin. 1993. Genetics and mechanisms of glycopeptide resistance in enterococci Antimicrob. Agents Chemother 37:1563-1571.
4. Bouanchaud, D. H. 1992. In-vitro and in-vivo synergic activity and fractional inhibitory concentration (FIC) of the components of a semisynthetic streptogramm, RP 59500. 3. Antimicrob. Chemother. 30(Suppl A):95-99.
5. Brumfitt, W., J. M. Hamilton-Miller, and S. Shah. 1992. In-vitro activity of RP 59500. a new semisynthetic streptogramin antibiotic, against gram-positive bacteria. J. Antimicrob. Chemother. 30(Suppl. A):29-37.
6. Clark, N. C., R. C. Cooksey. B. C. Hill, J. M. Swenson, and F. C. Tenover. 1993. Characterization of glycopeptide-resistant enterococci from U. S hospitals. Antimicrob. Agents Chemother. 37:2311-2317.
7. Collins, L. A., G. J. Malanoski, G. M. Eliopoulos, C. B. Wennersten, M. J. Ferraro, and R. C. Moellering, Jr. 1993 In vitro activity of RP 59500. an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms. Antimicrob. Agents Chemother. 37:598-601.
8. Desnottes, J. F., and N. Diallo. 1992 Cellular uptake and intracellular bactericidal activity of RP 59500 in murine macrophages. J. Antimicrob Chemother. 30(Suppl. A):107-115.
9. Etienne, S. D., G. Montay, A. Le Liboux, A. Frydman, and J. J. Garaud, 1992 A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500. J. Antimicrob. Chemother. 30(Suppl. A):123-131
10. Fass, R. J. 1991. In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci. Antimicrob. Agents Chemother 35:553-559.
11. Garcia, I., A. Pascual, M. C. Guzman, and E. J. Perea. 1992. Uptake and intracellular activity of sparfloxacin in human polymorphonuclear leukocytes and tissue culture cells. Antimicrob Agents Chemother. 36:1053-1056.
12. Goto, S., S. Miyazaki, and Y. Kaneko. 1992. The in-vitro activity of RP 59500 against gram-positive cocci, J. Antimicrob. Chemother. 30(Suppl A):25 28.
13. Hand, W. L., and N. L. King-Thompson. 1986 Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity Antimicrob Agents Chemother 29:135-140.
14. Handwerger, S., B. Raucher, D. Altarac, J. Monka, S. Marchione, K. V. Singh, B. E. Murray, J. Wolff, and B. Walters. 1993. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin and gentamicin. Clin. Infect. Dis. 16:750-753
15. Herrera-Insúa, I., K. Jacques-Palaz, B. E. Murray, and R. M. Rakita. 1995. Intracellular activity of RP 59500 (quinupnstin/dalfopristin). an injectable streptogramin, against Enterococcus faecium, abstr. E119, p. 106. In program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C
16. Ishiguro, M., H. Koga, S. Kohno, T. Hayashi, K. Yamaguchi, and M. Hirota. 1989 Penetration of macrolides into human polymorphonuclear leukocytes. J Antimicrob Chemother. 24:719-729.
17. Megran, D. W. 1992 Enterococcal endocarditis Clin Infect. Dis. 15:63-71.
18. Miranda, A. G., K. V. Singh, and B. E. Murray. 1991. DNA fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiologic tool. J. Clin. Microbiol. 29:2752-2757.
19. Mtairag, E. M., H. Abdelghaffar, C. Douhet, and M. T. Labro. 1995. Role of extracellular calcium in in-vitro uptake and intraphagocytic location of macrohdes Antimicrob Agents Chemother. 39:1676-1682.
20. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed Tentative standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
21. Perri, M. B., J. W. Chow, and M. J. Zervos. 1993. In vitro activity of sparfloxacin and clinafloxacin against multidrug-resistant enterococci Diagn. Microbiol. Infect. Dis. 17:153-155
22. Rakita, R. M., K. Jacques-Palaz, and B. E. Murray. 1994. Intracellular activity of azithromycin against bacterial enteric pathogens. Antimicrob. Agents Chemother. 38:1915-1921
23. Retsema, J. A., L. A. Brennan, and A, E. Girard. 1991. Effects of environmental factors on the in vitro potency of azithromycin. Eur. J. Clin. Microbiol. Infect. Dis. 10:834-842.
24. Richard, P., and L. Gutmann. 1992 Sparfloxacin and other new fluoroquinolones. J. Antimicrob. Chemother 30:739-744
25. Rosen, H., B. R. Michel, and A. Chait. 1991. Phagocytosis of opsonized oil droplets by neutrophils: adaptation to a microtiter plate format. J. Immunol Methods 144:117-125.
26. Schaberg, D. R., D. H. Culver, and R. P. Gaynes. 1991. Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 91:725-755.
27. Scorneaux, B., and P. M. Tulkens. 1994. Intracellular infection by L. pneumophila and 5. aureus modulates the subcellular distribution of fluoroquinolones but not that of macrolides in a model of J774 macrophages, abstr, E31, p. 157. In program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. Washington, D.C.
28. Spera, R. V., and B. F. Farber. 1992. Multiply-resistant Enterococcus faecium: the nosocomial pathogen of the 1990s. JAMA 268:2563-2564.
29. Steinberg, T. H. 1994. Cellular transport of drugs. Clin. Infect. Dis. 19: 916-921
30. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995 Interpreting chromosomal DNA restriction patterns produced by pulsed-fieid gel electrophoresis: criteria for bacterial strain typing J. Clin. Microbiol. 33:2233-2239.
31. Tulkens, P. M. 1991. Intracellular distribution and activity of antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 10:100-106
32. van den Broek, P. J. 1989. Antimicrobial drugs, microorganisms, and phagocytes. Rev. Infect Dis. 11:213-245.
33. van der Auwera, P., T. Matsumoto, and M. Hussen. 1988. Intraphagocytic penetration of antibiotics. J. Antimicrob. Chemother. 22:185-192.
34. Zemper, K., P. Schüller, H. Lode, K. Borner, and P. Koeppe. 1994. Comparative kinetics of sparfloxacin (SPX) and ciprofloxacin (CPX) in phagocytic cells, abstr. E 59, p. 20. In program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. Washington, D.C.